Target intelligence / Profile preview

Primary antibody paratope (Ab1 paratope) (Ab1 paratope)

Target
Ab1 paratope
Molecular classification
Antibody variable region, Idiotype
01

Overview

The Ab1 paratope refers to the specific antigen-binding site of a primary antibody (Ab1), characterized by its unique variable region sequences and complementarity-determining regions (CDRs). In the context of the idiotypic network theory, the Ab1 paratope acts as a target for anti-idiotypic antibodies (Ab2), which can regulate immune responses or serve as functional mimics of the original antigen. This target is particularly significant in oncology, where patient-specific B-cell lymphoma idiotypes (Ab1 paratopes) are used to develop personalized vaccines that elicit a targeted immune response against malignant cells. Additionally, the Ab1 paratope is a critical focus in the development of anti-idiotypic reagents for bioanalytical monitoring of therapeutic monoclonal antibodies, allowing for the detection of free drug levels and the assessment of anti-drug antibody (ADA) responses. Safety considerations for targeting the Ab1 paratope include the risk of forming circulating immune complexes and the potential for unintended molecular mimicry that could trigger autoimmune reactions.

Other names
IdiotypeAntibody 1 paratopeAb1 variable regionAntigen-binding site of Ab1Complementarity-determining regions of Ab1
02

Mechanism of action

Anti-idiotypic antibodies (Ab2) bind to the Ab1 paratope to mimic the original antigen (Ab2-beta) or to neutralize the primary antibody (Ab1).

03

Biological functions

Antigen recognitionImmune responseImmune regulationB-cell receptor signaling
04

Disease associations

CancerInfectionAutoimmune disease
05

Safety considerations

Immune complex formationMolecular mimicry leading to autoimmunityCytokine release syndrome
06

Interacting drugs

Racotumomab

3 more in the full profile.

07

Biomarkers

Anti-idiotypic antibody (Ab2) titersPrimary antibody (Ab1) serum concentrationB-cell idiotype expression (in B-cell lymphoma)

Beyond the preview

Go deeper on Primary antibody paratope (Ab1 paratope) (Ab1 paratope).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primary antibody paratope (Ab1 paratope) (Ab1 paratope).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call